T-cell-expression cloning of Porphyromonas gingivalis genes coding for T helper-biased immune responses during infection

被引:10
作者
Goncalves, Reginaldo B.
Leshem, Onir
Bernards, Karen
Webb, John R.
Stashenko, Philip P.
Campos-Neto, Antonio
机构
[1] Forsyth Inst, Boston, MA 02115 USA
[2] Univ Estadual Campinas, Piracicaba Sch Dent, Piracicaba, SP, Brazil
[3] Infect Dis Res Inst, Seattle, WA USA
[4] British Columbia Canc Agcy, Deeley Res Ctr, Victoria, BC, Canada
[5] Boston Univ, Henry M Goldman Sch Dent Med, Boston, MA 02215 USA
关键词
D O I
10.1128/IAI.02029-05
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Exposure of the mouse oral cavity to Porphyromonas gingivalis results in the development of gingivitis and periapical bone loss, which apparently are associated with a Th1 response to bacterial antigens. We have used this infection model in conjunction with direct T-cell expression cloning to identify bacterial antigens that induce a preferential or biased T helper response during the infectious process. A P. gingivalis-specific CD4 T-cell line derived from mice at 3 weeks postchallenge was used to directly screen a P. gingivalis genomic expression library. This screen resulted in the identification of five genes coding for previously identified proteins and three other putative protein antigens. One of the identified proteins, P. gingivalis thiol peroxidase, was studied in detail because this molecule belongs to a protein family that is apparently involved in microbial pathogenesis. Infection of mice with P. gingivalis, either via the subcutaneous route or after exposure of the animal's oral cavity to viable bacteria, resulted in the induction of a strong thiol peroxidase-specific immune response characterized by the production of high titers of specific serum immunoglobulin G2a antibody and the production of gamma interferon by antigen-stimulated lymphoid cells, a typical Th1-biased response. Thus, the use of a proven T-cell expression cloning approach and a mouse model of periodontal disease resulted in the identification and characterization of P. gingivalis proteins that might be involved in pathogenesis.
引用
收藏
页码:3958 / 3966
页数:9
相关论文
共 47 条
[1]   THE ADJUVANT EFFECT OF INTERLEUKIN-12 IN A VACCINE AGAINST LEISHMANIA-MAJOR [J].
AFONSO, LCC ;
SCHARTON, TM ;
VIEIRA, LQ ;
WYSOCKA, M ;
TRINCHIERI, G ;
SCOTT, P .
SCIENCE, 1994, 263 (5144) :235-237
[2]   Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4+ T cells [J].
Alderson, MR ;
Bement, T ;
Day, CH ;
Zhu, LQ ;
Molesh, D ;
Skeiky, YAW ;
Coler, R ;
Lewinsohn, DM ;
Reed, SG ;
Dillon, DC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (03) :551-559
[3]   ORAL INFECTION WITH PORPHYROMONAS-GINGIVALIS AND INDUCED ALVEOLAR BONE LOSS IN IMMUNOCOMPETENT AND SEVERE COMBINED IMMUNODEFICIENT MICE [J].
BAKER, PJ ;
EVANS, RT ;
ROOPENIAN, DC .
ARCHIVES OF ORAL BIOLOGY, 1994, 39 (12) :1035-1040
[4]   Serum antibody response to oral infection precedes but does not prevent Porphyromonas gingivalis-induced alveolar bone loss in mice [J].
Baker, PJ ;
Carter, S ;
Dixon, M ;
Evans, RT ;
Roopenian, DC .
ORAL MICROBIOLOGY AND IMMUNOLOGY, 1999, 14 (03) :194-196
[5]   Interleukin-6 deficiency increases inflammatory bone destruction [J].
Balto, K ;
Sasaki, H ;
Stashenko, P .
INFECTION AND IMMUNITY, 2001, 69 (02) :744-750
[6]   THE CAPABILITY OF ACTINOBACILLUS-ACTINOMYCETEMCOMITANS, BACTEROIDES-GINGIVALIS AND BACTEROIDES-INTERMEDIUS TO INDICATE PROGRESSIVE PERIODONTITIS - A RETROSPECTIVE STUDY [J].
BRAGD, L ;
DAHLEN, G ;
WIKSTROM, M ;
SLOTS, J .
JOURNAL OF CLINICAL PERIODONTOLOGY, 1987, 14 (02) :95-99
[7]   What about Th1/Th2 in cutaneous leishmaniasis vaccine discovery? [J].
Campos-Neto, A .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2005, 38 (07) :979-984
[8]   Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease [J].
Campos-Neto, A ;
Porrozzi, R ;
Greeson, K ;
Coler, RN ;
Webb, JR ;
Seiky, YAW ;
Reed, SG ;
Grimaldi, G .
INFECTION AND IMMUNITY, 2001, 69 (06) :4103-4108
[9]  
CHAE HZ, 1994, J BIOL CHEM, V269, P27670
[10]  
Compos-Neto A, 1998, J IMMUNOL, V160, P2037